
-
Scheffler grabs PGA lead with sizzling 61 at CJ Cup Byron Nelson
-
'Divine dreams' and 38 virgins at Trump prayer event
-
Apple expects $900 mn tariff hit, US iPhone supply shifts to India
-
Lakers prepare for offseason rebuild after playoff exit
-
'Natural' for stars like Maguire to deliver now: Man Utd's Amorim
-
EU preparing new sanctions on Russia, French minister tells AFP
-
Apple expects $900 mn tariff hit as shifts US iPhone supply to India
-
US to end shipping loophole for Chinese goods Friday
-
Forest's Champions League dreams hit by Brentford defeat
-
Norris and Piastri taking championship battle in their stride
-
Chelsea close in on UEFA Conference League final with win at Djurgarden
-
Spurs take control in Europa semi against Bodo/Glimt
-
Man Utd seize control of Europa League semi against 10-man Bilbao
-
With minerals deal, Ukraine finds way to secure Trump support
-
Amazon revenue climbs 9%, but outlook sends shares lower
-
Trump axes NSA Waltz after chat group scandal
-
Forest Champions League dreams hit after Brentford defeat
-
'Resilient' Warriors aim to close out Rockets in bruising NBA playoff series
-
US expects Iran talks but Trump presses sanctions
-
Baffert returns to Kentucky Derby, Journalism clear favorite
-
Top Trump security official replaced after chat group scandal
-
Masked protesters attack Socialists at France May Day rally
-
Mumbai eliminate Rajasthan from IPL playoff race with bruising win
-
McDonald's profits hit by weakness in US market
-
Rio goes Gaga for US singer ahead of free concert
-
New research reveals where N. American bird populations are crashing
-
Verstappen late to Miami GP as awaits birth of child
-
Zelensky says minerals deal with US 'truly equal'
-
Weinstein lawyer says accuser sought payday from complaint
-
Police arrest more than 400 in Istanbul May Day showdown
-
Herbert named head coach of Canada men's basketball team
-
'Boss Baby' Suryavanshi falls to second-ball duck in IPL
-
Shibutani siblings return to ice dance after seven years
-
300,000 rally across France for May 1, union says
-
US-Ukraine minerals deal: what we know
-
Top Trump official ousted after chat group scandal: reports
-
Schueller hat-trick sends Bayern women to first double
-
Baudin in yellow on Tour de Romandie as Fortunato takes 2nd stage
-
UK records hottest ever May Day
-
GM cuts 2025 outlook, projects up to $5 bn hit from tariffs
-
Thousands of UK children write to WWII veterans ahead of VE Day
-
Top Trump official exiting after chat group scandal: reports
-
Madrid Open holder Swiatek thrashed by Gauff in semis
-
Sheinbaum says agreed with Trump to 'improve' US-Mexico trade balance
-
US veteran convicted of quadruple murder to be executed in Florida
-
UK counter terrorism police probe Irish rappers Kneecap
-
S. Korea crisis deepens with election frontrunner retrial, resignations
-
Trump administration releases report critical of youth gender care
-
IKEA opens new London city centre store
-
Police deploy in force for May Day in Istanbul, arrest hundreds

Animal testing put to the test in Swiss vote
Switzerland goes to the polls Sunday to decide whether animal and human testing should be banned -- a proposal that has triggered an outcry in a country heavily reliant on big pharma.
Opinions suggest that the proposal by animal rights defenders is highly unlikely to pass.
But if it did, "Switzerland would be the only country internationally with such a ban," said Yves Fluckiger, president of the Swiss universities lobby group.
Researchers insist that medical progress is impossible without experimentation.
At the University of Geneva, Patrycja Nowak-Sliwinska, head of the molecular pharmacology laboratory, unveils her cell incubator where intestinal organoids from cancer patients are being cultivated.
These structures, made up of cells, make it possible to test a large number of potential treatments.
"With the in vitro model, we try to find promising candidates" -- and only the latter would then be tested on animals, said Nowak-Sliwinska, who received a prize rewarding researchers who work to replace animals with other methods.
But even she said it would be impossible to do all the research without animal experimentation and clinical trials.
This is why the university's Faculty of Medicine has an animal facility in the basement housing some 25,000 animals -- mostly mice and rats.
- Strict protocols -
Inside, Professor Doron Merkler conducts research to find a treatment for a form of multiple sclerosis.
The research could not advance without using mice, into which he injects modified cells to observe how the disease affects the nervous system.
The mouse he is working on is showing symptoms: instability, difficulty moving, and partial paralysis of the limbs.
The experiments are framed by a strict protocol regarding their degree of severity, and animal keepers are trained to detect when an animal is not well.
"If no veterinary care can be provided to the animal, we can decide with the researcher to sacrifice it," said Pierre Bonnaventure, head of animal facilities at the faculty.
In Switzerland, researchers seeking to use live animals must make a formal request, establish that there is no alternative method available and that the conditions imposed on the animals will be as light as possible.
The number of animals used has consequently fallen sharply, from nearly two million per year in the early 1980s to around 560,000.
Some 20,000 animals a year undergo severe interventions, such as the implantation of a tumour, according to federal authorities.
- Proposal 'goes too far' -
Under Switzerland's direct democracy system, campaigners collected enough signatures to trigger a popular vote.
The proposal would outlaw experiments not only on animals but on humans too, as well as ban the importation of new drugs developed through such means.
"Animal experiments should be considered a crime," Renato Werndli, a doctor among those who launched the initiative, told AFP.
All the major political parties in Switzerland are against the proposal.
For the government, the ban "goes too far" and would have "serious consequences for health" -- and also for the economy, in a country where the chemical and pharmaceutical sector represents just over half of all exports.
Interpharma, the Swiss pharmaceutical industry's lobby group, warned that in the event of a ban, "the institutions and companies concerned would be forced to relocate their activities abroad".
Switzerland has already rejected three initiatives on the subject -- in 1985 (70 percent), 1992 (56 percent) and 1993 (72 percent) -- and is expected to do likewise this time.
But it remains to be seen whether the majority will be as big, in a society where animal welfare has grown in importance.
For Samia Hurst, a bioethicist at the University of Geneva, the new initiative commits "a fairly frequent mistake, which is to target biomedical research".
However, she told AFP: "Animal experimentation, among the various uses that humanity makes of other species, is both the most closely monitored and undoubtedly the most justified."
O.Norris--AMWN